24 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

LLY

Eli Lilly
US$777.961.0%126.5%US$700.8bUS$797.44PE133.7xE27.2%0.7%

ABBV

AbbVie
US$182.102.0%14.3%US$322.4bUS$183.88PE66.9xE23.1%3.4%

BMY

Bristol-Myers Squibb
US$54.234.4%-21.8%US$109.9bUS$56.41PE13.7xE7.8%4.4%

VRTX

Vertex Pharmaceuticals
US$418.010.6%32.7%US$108.0bUS$459.71PE29.8xE11.2%n/a

GILD

Gilead Sciences
US$73.250.9%-11.7%US$91.3bUS$86.45PE16.1xE6.5%4.2%

ZTS

Zoetis
US$169.210.2%1.7%US$77.5bUS$221.93PE33.1xE8.1%1.0%

IQV

IQVIA Holdings
US$252.890.2%27.2%US$46.0bUS$273.70PE33.9xE12.7%0%

WST

West Pharmaceutical Services
US$395.710.5%14.2%US$29.0bUS$390.58PE48.8xE8.3%0.2%

BRKR

Bruker
US$93.940.04%19.2%US$12.9bUS$84.40PE30.3xE2.5%0.2%

ALKS

Alkermes
US$27.07-0.8%-4.0%US$4.5bUS$34.83PE8.7xE-16.1%n/a

CORT

Corcept Therapeutics
US$25.192.8%16.3%US$2.6bUS$42.80PE24.7xE26.2%n/a

AMPH

Amphastar Pharmaceuticals
US$43.910.5%17.1%US$2.1bUS$64.80PE15.4xE19.3%n/a

HRMY

Harmony Biosciences Holdings
US$33.580.8%2.8%US$1.9bUS$41.63PE14.8xE25.8%n/a

PNT

POINT Biopharma Global
US$12.500.2%75.1%US$1.3bUS$12.50PE13.8xE9.2%n/a

COLL

Collegium Pharmaceutical
US$38.82-2.3%61.8%US$1.2bUS$40.00PE25.8xE25.4%n/a

MDXG

MiMedx Group
US$7.70-4.2%125.8%US$1.1bUS$12.44PE20.3xE15.0%n/a

INVA

Innoviva
US$15.241.0%35.5%US$963.6mUS$15.00PE5.4xS5.5%0%

SIGA

SIGA Technologies
US$8.56-2.3%48.9%US$608.5mn/aPE8.9xE6.6%7.0%

PBYI

Puma Biotechnology
US$5.30-0.6%71.5%US$255.5mUS$4.33PE11.8xE-53.5%n/a

ELTP

Elite Pharmaceuticals
US$0.152.1%432.2%US$157.1mn/aPE10.1xn/an/a

SPRO

Spero Therapeutics
US$1.72-1.7%18.6%US$92.7mUS$7.50PE4.1xE-2.9%n/a

PLX

Protalix BioTherapeutics
US$1.26-0.8%-40.0%US$92.0mUS$13.00PE11.1xE96.5%n/a

MEIP

MEI Pharma
US$4.004.4%-12.6%US$26.7mUS$23.00PE1.3xE-47.4%n/a

XCUR

Exicure
US$0.60-4.3%-30.9%US$5.2mn/aPE1.7xn/an/a
Page 1 of 1
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.